pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
micvotabart pelidotin
micvotabart pelidotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$PYXSPyxis Oncology, Inc.
0 catalysts
Phase 2
mifomelatide
mifomelatide [INN]
Cancer Anorexia-Cachexia Syndrome
Kalohexis LLC
0 catalysts
Phase 2
milrinone ER
milrinone
Congestive Heart Failure (Heart Failure)
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Hyloris Pharmaceuticals SA
← prev
page 43 of 53
next →
131
Pain89
Neurology1
0 catalysts
Phase 2
mipletamig
mipletamig [INN]
Refractory Acute Myeloid Leukemia
$APVOAptevo Therapeutics Inc.
0 catalysts
Phase 2
miransertib mesylate
Proteus Syndrome
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
mirdametinib
Gomekli (mirdametinib)
Non-Small Cell Lung Cancer
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
SpringWorks Therapeutics Inc
0 catalysts
Phase 2
misoprostol
Misoprostol Greenstone (misoprostol)
Labor And Delivery
Prostaglandin E2 receptor EP3 subtype
AFYX Therapeutics A/S
0 catalysts
Phase 2
mitazalimab
mitazalimab [INN]
Pancreatic Ductal Adenocarcinoma
Alligator Bioscience AB
0 catalysts
Phase 2
mitolactol
mitolactol [INN]
Glioblastoma Multiforme (GBM)
Eleison Pharmaceuticals Inc
0 catalysts
Phase 2
mocaciclib
mocaciclib [INN]
Endometrial Cancer
Qurient Co Ltd
0 catalysts
Phase 2
mometasone furoate
Sinuva (mometasone furoate)
Eosinophilic Esophagitis
Glucocorticoid receptor
EsoCap AG
0 catalysts
Phase 2
monlunabant
monlunabant [INN]
Diabetic Nephropathy
Inversago Pharma Inc
0 catalysts
Phase 2
mosedipimod
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Enzychem Lifesciences Corp
0 catalysts
Phase 2
moxidectin
Moxidectin (moxidectin)
Scabies
Atticus Medical Pty Ltd
0 catalysts
Phase 2
mozistobart zoratolimod
mozistobart zoratolimod [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Tallac Therapeutics Inc
0 catalysts
Phase 2
mupadolimab
Non-Small Cell Lung Cancer
$CRVSCorvus Pharmaceuticals, Inc.
0 catalysts
Phase 2
muzastotug
muzastotug [INN]
Solid Tumor
$ADAGAdagene Inc.
0 catalysts
Phase 2
nLLMNB1-001
Leukodystrophies
n-Lorem Foundation
0 catalysts
Phase 2
nLTUBB4-001
Leukodystrophies
n-Lorem Foundation
0 catalysts
Phase 2
narmafotinib tartrate
Metastatic Adenocarcinoma of The Pancreas
Amplia Therapeutics Ltd
0 catalysts
Phase 2
naronapride
Diabetic Gastroparesis
5-hydroxytryptamine receptor 4
Renexxion LLC
0 catalysts
Phase 2
navicixizumab
Fallopian Tube Cancer
Feng Biosciences Inc
0 catalysts
Phase 2
navtemadlin
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Tumour suppressor p53/oncoprotein Mdm2
Kartos Therapeutics Inc
0 catalysts
Phase 2
naxitamab
Danyelza (naxitamab-gqgk)
Neuroblastoma
Y-mAbs Therapeutics Inc
0 catalysts
Phase 2
nebokitug
Primary Sclerosing Cholangitis
$CMMBChemomab Therapeutics Ltd.
0 catalysts
Phase 2
nedometinib
Neurofibromatoses Type I (Von Recklinghausen's Disease)
NFlection Therapeutics Inc
0 catalysts
Phase 2
neflamapimod
Frontotemporal Dementia (Pick Disease)
Mitogen-activated protein kinase 14
$CRVOCervoMed Inc.
0 catalysts
Phase 2
nemolizumab
Nemluvio (nemolizumab)
Systemic Sclerosis (Scleroderma)
Interleukin-31 receptor subunit alpha
Galderma SA
0 catalysts
Phase 2
nemonoxacin
Taigexyn (nemonoxacin [INN])
Diabetic Foot Infection (DFI)
TaiGen Biotechnology Co Ltd
0 catalysts
Phase 2
nemtabrutinib
Follicular Lymphoma
$MRKMerck & Co., Inc.
0 catalysts